SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

23.75p
   
  • Change Today:
    -1.75p
  • 52 Week High: 26.10
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 232.98m
  • Volume: 2,422,805
  • Market Cap: £55.33m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Executive Director: Simon Hewitson
Group Finance Director: Emily Bertram
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 23.75p
Change Today -1.75p
% Change -6.86 %
52 Week High 26.10
52 Week Low 8.50
Volume 2,422,805
Shares Issued 232.98m
Market Cap £55.33m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.22% below the market average72.22% below the market average72.22% below the market average72.22% below the market average72.22% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Price Trend
94.14% above the market average94.14% above the market average94.14% above the market average94.14% above the market average94.14% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
48.20% above the market average48.20% above the market average48.20% above the market average48.20% above the market average48.20% above the market average
68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average

SBTX Dividends

No dividends found

Trades for 29-Apr-2025

Time Volume / Share Price
15:39 200,000 @ 23.60p
16:01 30,000 @ 23.66p
16:01 30,000 @ 23.76p
16:00 374 @ 24.15p
15:58 12,677 @ 23.76p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page